Deutsche Bank Adjusts Omega Healthcare Investors Price Target to $46 From $38, Maintains Buy Rating
Omega Healthcare Price Target Raised to $39.00/Share From $33.00 by Scotiabank
Scotiabank Maintains Sector Perform on Omega Healthcare Invts, Raises Price Target to $39
Omega Healthcare Invts Analyst Ratings
Scotiabank Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $39
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Raises Target Price to $40
Wells Fargo Sticks to Their Buy Rating for Omega Healthcare (OHI)
Citi Initiates Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Announces Target Price $42
Scotiabank Reaffirms Their Hold Rating on Omega Healthcare (OHI)
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $39
Mizuho Downgrades Omega Healthcare Investors to Neutral From Outperform, Adjusts Price Target to $35 From $34
Scotiabank Adjusts Price Target on Omega Healthcare Investors to $33 From $32, Maintains Sector Perform Rating
Scotiabank Maintains Sector Perform on Omega Healthcare Invts, Raises Price Target to $33
Omega Healthcare Invts Analyst Ratings
Omega Healthcare Invts Analyst Ratings
Truist Securities Adjusts Omega Healthcare Investors Price Target to $33 From $32, Maintains Hold Rating
Deutsche Bank Adjusts Omega Healthcare Investors Price Target to $38 From $36, Maintains Buy Rating
RBC Lifts Price Target on Omega Healthcare Investors to $32 From $31, Keeps Sector Perform Rating
Omega Healthcare Invts Analyst Ratings